Moderately bullish activity in Novo Nordisk (NVO), with shares up 8c, or 0.19%, near $45.77. Options volume running well above average with 52k contracts traded and calls leading puts for a put/call ratio of 0.33, compared to a typical level near 0.72. Implied volatility (IV30) is higher by 1.3 points near 53.9,in the top quartile of the past year, suggesting an expected daily move of $1.55. Put-call skew steepened, indicating increased demand for downside protection.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVO:
- Novo Nordisk price target lowered to DKK 315 from DKK 375 at BofA
- Viking Therapeutics Stock (VKTX) Jumps on Obesity Drug. The Next Big Pharma Target?
- Video: Health insurers weighed on by shutdown news, Trump post
- Morning Movers: Monday.com sinks following third quarter results
- Novo Nordisk Stock (NVO) Rises on Plan to Pursue Other Obesity Deals after Metsera Loss